Balyasny Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-49,250
| Closed | -$3.85M | – | 2167 |
|
2024
Q4 | $3.85M | Buy |
+49,250
| New | +$3.85M | 0.01% | 926 |
|
2024
Q2 | – | Sell |
-90,674
| Closed | -$7.74M | – | 2114 |
|
2024
Q1 | $7.74M | Buy |
90,674
+44,728
| +97% | +$3.82M | 0.01% | 759 |
|
2023
Q4 | $3.93M | Buy |
+45,946
| New | +$3.93M | 0.01% | 848 |
|
2023
Q3 | – | Sell |
-54,733
| Closed | -$4.66M | – | 1942 |
|
2023
Q2 | $4.66M | Sell |
54,733
-98,229
| -64% | -$8.36M | 0.01% | 801 |
|
2023
Q1 | $12.7M | Buy |
+152,962
| New | +$12.7M | 0.03% | 543 |
|
2022
Q4 | – | Sell |
-243,677
| Closed | -$18M | – | 2478 |
|
2022
Q3 | $18M | Sell |
243,677
-302,999
| -55% | -$22.4M | 0.06% | 382 |
|
2022
Q2 | $35.6M | Buy |
+546,676
| New | +$35.6M | 0.12% | 191 |
|
2022
Q1 | – | Sell |
-355,127
| Closed | -$18.8M | – | 2269 |
|
2021
Q4 | $18.8M | Buy |
355,127
+14,311
| +4% | +$759K | 0.06% | 365 |
|
2021
Q3 | $24.1M | Buy |
340,816
+328,682
| +2,709% | +$23.2M | 0.1% | 249 |
|
2021
Q2 | $809K | Buy |
+12,134
| New | +$809K | ﹤0.01% | 1183 |
|
2021
Q1 | – | Sell |
-164,944
| Closed | -$19.6M | – | 1701 |
|
2020
Q4 | $19.6M | Sell |
164,944
-97,076
| -37% | -$11.5M | 0.11% | 237 |
|
2020
Q3 | $22.9M | Buy |
262,020
+135,596
| +107% | +$11.8M | 0.17% | 143 |
|
2020
Q2 | $11.3M | Buy |
+126,424
| New | +$11.3M | 0.1% | 263 |
|
2020
Q1 | – | Sell |
-175,119
| Closed | -$20.1M | – | 1166 |
|
2019
Q4 | $20.1M | Buy |
+175,119
| New | +$20.1M | 0.12% | 245 |
|
2019
Q2 | – | Sell |
-8,846
| Closed | -$774K | – | 1416 |
|
2019
Q1 | $774K | Buy |
+8,846
| New | +$774K | 0.01% | 985 |
|
2018
Q3 | – | Sell |
-4,953
| Closed | -$444K | – | 1568 |
|
2018
Q2 | $444K | Buy |
+4,953
| New | +$444K | ﹤0.01% | 1205 |
|
2017
Q4 | – | Sell |
-7,730
| Closed | -$347K | – | 1866 |
|
2017
Q3 | $347K | Sell |
7,730
-58,570
| -88% | -$2.63M | ﹤0.01% | 1265 |
|
2017
Q2 | $2.62M | Buy |
+66,300
| New | +$2.62M | 0.01% | 722 |
|